Cystadane (betaine)

Betaine Oral Powder (Gram)

Advertisement

Last reviewed · Source: First Databank (FDB) drug data

Overview

Betaine is a methyl group donor that functions in the normal metabolic cycle of methionine and reduces homocystinuria in patients with inborn errors of methionine metabolism.

Betaine, a methyl group donor that functions in the normal metabolic cycle of methionine, occurs naturally in the body as a metabolite of choline and is present in foods such as beets, spinach, cereals, and seafood. However, natural dietary sources provide betaine in amounts insufficient to be therapeutic in patients with homocystinuria.

In patients with inborn errors of methionine metabolism and resultant homocystinuria, oral administration of betaine at recommended pharmacologic dosages results in reduction of elevated plasma concentrations of homocysteine through the action of betaine functioning as a methyl group donor in the remethylation of homocysteine to methionine. Remethylation of homocysteine to methionine is catalyzed by betaine-homocysteine S-methyltransferase and does not require 5-methyltetrahydrofolate or methylcobalamin cofactors. Because this reaction does not depend on these cofactors, betaine is effective in all 3 primary forms of homocystinuria (i.e., cystathionine beta-synthase (CBS) deficiency, 5,10-methylenetetrahydrofolate reductase (MTHFR) deficiency, and cobalamin cofactor metabolism (cbl) defect).

Betaine also can increase low plasma methionine and S-adenosylmethionine (SAM) concentrations in patients with MTHFR deficiency or cbl defect. Elevations in plasma homocysteine concentrations in conditions other than homocystinuria also have been reported.

Betaine is commercially available as an anhydrous powder, and potency of the drug is expressed on the anhydrous basis.

SumMon(R) (see Users Guide). For additional information on this drug until a more detailed monograph is developed and published, the manufacturer's labeling should be consulted. It is essential that the labeling be consulted for detailed information on the usual cautions, precautions, and contraindications.

USES: This medication is used to treat high levels of a certain important body chemical (homocysteine) due to an inherited disorder (homocystinuria). Decreasing high homocysteine levels may help prevent serious blood clots, abnormal bone formation, brittle bones (osteoporosis), and eye problems (such as dislocated eye lens, nearsightedness). This medication works by decreasing blood levels of homocysteine.

It does not correct the inherited disorder that causes the disease.

Generic name: betaine
Pronunciation: (BEE-ta-een)
Drug class: Betaine
Therapeutic class: Metabolic Modifiers

Reference product & biosimilars

No reference, biosimilar or interchangeable associated with this drug.

Today’s intelligence on Cystadane

Intelligence content is not available yet.

Indications

The following indications are listed for Cystadane:

  • Homocystinuria

Also known as: Cystathionine Synthase Deficiency.

Dosing

Dosage of betaine is expressed in terms of anhydrous drug.

The usual dosage of betaine for the management of homocystinuria in adults and children is 6 g daily administered in 2 equally divided doses. Although children ranging in age from several months to years have been treated successfully and without unusual adverse effects with 6 g daily, dosage titration may be preferable in children. Children younger than 3 years of age may receive an initial betaine dosage of 100 mg/kg daily that is subsequently increased at weekly intervals in increments of 100 mg/kg daily.

All patients may receive gradual increases in betaine dosage until the concentration of homocysteine in plasma is undetectable or present only in small amounts. Some patients have required up to 20 g daily to control concentrations of homocystine in plasma.

Drug interactions

There is no enhanced messaging for this drug.

Contraindications

There is no enhanced messaging for this drug.

Adverse reactions

There is no enhanced messaging for this drug.

Precautions

No enhanced messaging available.

ICD codes

CodeTypeDescription
Homocystinuria
E72.11ICD10CMHomocystinuria

ICD code information from First Databank (FDB).

Formulary status

Search health-plan coverage for this drug by ZIP code.

Enter a ZIP code to view available health plans.

Last reviewed · Source: First Databank (FDB) drug data